Frequency of CD39+, LAG3+, and CTLA4+ Regulatory T Cells in Two Different Immunosuppressive Protocols in Renal Allograft Recipients (Sirolimus vs Mycophenolate mofetil): A Cohort Report
Background: Impaired renal function is considered as a significant risk factor for cardiovascular events in chronic kidney disease patients. Several immunosuppressive drugs are used in these patients, which necessitates to minimize the drug-related side effects by employing alternative strategies.Ob...
Main Authors: | Yaghoub Mollaei-Kandelous, Pedram Ahmadpoor, Mohsen Nafar, Mohammad Reza Khatami, Samad Farashi Bonab, Nader Tajik, Mahdi Shekarabi, Aliakbar Amirzargar |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2022-09-01
|
Series: | Iranian Journal of Immunology |
Subjects: | |
Online Access: | https://iji.sums.ac.ir/article_48683_f096c9a3a0577b71352caad6ea8c334f.pdf |
Similar Items
-
EVALUATION OF THE CONTENT OF CD4+CD25+CD127LOW REGULATORY T CELLS AND THEIR FUNCTIONAL STATUS ACCORDING TO THE EXPRESSION OF CTLA-4 AND CD39 MOLECULES IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. A. Zhulai, et al.
Published: (2014-06-01) -
Mycophenolate mofetil enhances the negative effects of sirolimus and tacrolimus on rat kidney cell metabolism.
by: Jelena Klawitter, et al.
Published: (2014-01-01) -
Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01) -
Impact of CTLA-4 checkpoint antibodies on ligand binding and Transendocytosis
by: Cayman Williams, et al.
Published: (2022-08-01) -
Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.
by: Flechner, S, et al.
Published: (2005)